SERIBANTUMAB
UNII 1N3L70MDFX

Substance Identification & Data

This profile provides standardized clinical and technical data for Seribantumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1N3L70MDFX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1334296-12-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

1N3L70MDFX

CAS Registry Number

1334296-12-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SERIBANTUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C78859

National Cancer Institute reference terminology for clinical and research data.

INN ID

9710

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

BC-136

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Seribantumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SERIBANTUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G2A, ANTI-(HUMAN NEUREGULIN RECEPTOR HER3) (HUMAN MONOCLONAL MM-121 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MM-121 .LAMBDA.-CHAIN, DIMER

SERIBANTUMAB [INN]

SERIBANTUMAB [USAN]

SERIBANTUMAB [WHO-DD]